Large-vessel involvement in giant cell arteritis

Current Opinion in Rheumatology

Volumn 18, Issue 1, 2006, Pages 10-17

  Bongartz, Tim ^a   Matteson, Eric L ^a  

^a Mayo Clinic   (United States)

Author keywords

Aneurysm; Giant cell arteritis; Large vessel disease; Stenosis

Indexed keywords

GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE;

ABDOMINAL AORTA ANEURYSM; ALGORITHM; ANGIOGRAPHY; AORTA DISSECTING ANEURYSM; AORTA STENOSIS; AORTITIS; CLAUDICATION; DIAGNOSTIC PROCEDURE; GANGRENE; GENOMICS; GIANT CELL ARTERITIS; HUMAN; LIFE EXPECTANCY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; REVIEW; SURVIVAL; THORACIC AORTA ANEURYSM; UNSPECIFIED SIDE EFFECT; AORTA ANEURYSM; AORTA DISEASE; PATHOLOGY; STENOSIS, OCCLUSION AND OBSTRUCTION; TEMPORAL ARTERITIS;

ALGORITHMS; AORTIC ANEURYSM; AORTIC DISEASES; AORTITIS; CONSTRICTION, PATHOLOGIC; HUMANS; TEMPORAL ARTERITIS;

EID: 33645458463     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000197996.04709.4e     Document Type: Review

References (41)

1. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33:1122-1128.
2. Nuenninghoff DM, Hunder GG, Christianson TJH, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003; 48:3522-3531.
3. Sproul E. A case of temporal arteritis (CPC). NY State J Med 1942; 42:345-347.
4. McMillan G. Diffuse granulomatous aortitis with giant cells associated with partial rupture and dissection of the aorta. Arch Pathol 1950; 49:63-69.
5. Magarey F. Dissecting aneurysm due to giant cell arteritis. J Pathol Bacteriol 1950; 62:445-446.
6. Reid J. Dilatation of the aorta due to granulomatous (giant cell) aortitis. Br Heart J 1957; 19:206-210.
7. Oestberg G. Morphological changes in the large arteries in polymyalgia arteritica. Acta Med Scand Suppl 1972; 533:135-164.
8. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108:246-249.
9. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med 1995; 122:502-507.
10. Evans JM, Bowles CA, Björnsson J, et al. Thoracic aortic aneurysm and rupture in giant cell arteritis: a descriptive study of 41 cases. Arthritis Rheum 1994; 37:1539-1547.
11. Jennings G. Arteritis of the temporal vessels. Lancet 1938; 1:424-428.
12. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell temporal arteritis. Ann Intern Med 1975; 83:806-812.
13. Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42:311-317.
14. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347:261-271.
15. Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine 2004; 83:335-341.
16. Nuenninghoff DM, Warrington KJ, Matteson EL. Concomitant giant cell aortitis, thoracic aortic aneurysm, and aortic arch syndrome: occurrence in patient and significance. Arthritis Rheum 2003; 49:858-861.
17. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003; 139:505-515.
18. Gonzalez-Gay MA, Boiardi L, Garcia-Porrua C, et al. Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in Southern Europe. J Rheumatol 2004; 31:520-523. A well performed study of factors influencing disease expression in two European populations finding no environmental or genetic factors accounting for disease phenotypes with an emphasis on systemic and cranial disease.
19. Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, et al. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998; 25:2140-2145.
20. Salvarani C, Boiardi L, Mantovani V, et al. HLA-DRB1, DQA1, and DQB1 alleles associated with giant cell arteritis in Northern Italy. J Rheumatol 1999; 26:2395-2399.
21. Salvarani C, Casali B, Boiardi L, et al. ICAM-I gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J Rheumatol 2000; 27:1215-1221.
22. Weyand CM, Fulbright JW, Hunder GG, et al. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum 2000; 43:1041-1048.
23. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Rheum 2001; 45:140-145.
24. Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994; 120:987-992.
25. Stanson AW. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 2000; 18 (Suppl 20):S43-S48.
26. Tso E, Flamm SD, White RD, et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002; 46:1634-1642.
27. Blockmans D. Utility of imaging studies in assessment of vascular inflammation. Cleve Clin J Med 2002; 69 (Suppl 2):SII95-SII99.
28. Ashton HA, Buxton MJ, Day NE, et al. Multicentre aneurysm screening study group: the multicentre aneurysm screening study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomized controlled trial. Lancet 2002; 360:1531-1539.
29. Isselbacher EM. Thoracic and abdominal aneurysms. Circulation 2005; 111:816-828.
30. Nuenninghoff DM, Matteson EL. The role of disease-modifying anti-rheumatic drugs in the treatment of giant cell arteritis. Clin Exp Rheumatol 2003; 21:29-34.
31. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995; 24:422-431.
32. Nesher G, Berkun Y, Mates M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004; 50:1332-1337.
33. Weyand C, Kaiser M, Yang H, et al. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002; 46:457-466.
34. Amann-Vesti BR, Koppensteiner R, Rainoni L, et al. Immediate and long-term outcome of upper extremity balloon angioplasty in giant cell arteritis. J Endovasc Ther 2003; 10:371-375.
35. Tyagi S, Verma PK, Gambhir DS, et al. Early and long-term results of subclavian angioplasty in aortoarteritis (Takayasu disease): comparison with atherosclerosis. Cardiovasc Intervent Radiol 1998; 21:219-224.
36. Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term beta adrenergic blockade in Marfan's syndrome. N Engl J Med 1994; 330:1335-1341.
37. Gadowski GR, Pilcher DB, Ricci MA. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 1994; 19:727-731.
38. Nuenninghoff DM, Hunder GG, Christianson TJH, et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis. Arthritis Rheum 2003; 48:3532-3537.
39. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996; 100:193-196.
40. Uddhammar A, Eriksson AL, Nystrom L, et al. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in Northern Sweden. J Rheumatol 2002; 29:737-742.
41. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989; 299:549-550.